Zdrowie i gospodarka · 28.10.2015
Product Development Under the Animal Rule; Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled "Product Development Under the Animal Rule." When human efficacy studies are not ethical and field trials are not feasible, FDA may rely on adequate and well-controlled animal efficacy studies to support approval of a drug or licensure of a biological product under the Animal Rule. This guidance finalizes the 2014 revised draft guidance for industry "Product Development Under the Animal Rule." It is intended to help potential stakeholders (industry, academia, and government) understand FDA's expectations for product development under the Animal Rule.